Genexine, Inc.
095700.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
2
Cost of Revenue
3
Gross Profit
-1
Gross Margin
-42.3%
Operating Income
-28
Operating Margin
-1270.0%
Net Income
-48
Net Margin
-2172.2%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-43
EBITDA Margin
-1954.9%
2023
12/31/2023
Revenue
3
Cost of Revenue
3
Gross Profit
0
Gross Margin
6.8%
Operating Income
-31
Operating Margin
-947.2%
Net Income
-50
Net Margin
-1510.7%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-31
EBITDA Margin
-923.5%
2022
12/31/2022
Revenue
12
Cost of Revenue
7
Gross Profit
5
Gross Margin
45.3%
Operating Income
-23
Operating Margin
-192.7%
Net Income
-42
Net Margin
-346.8%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-22
EBITDA Margin
-178.5%
2021
12/31/2021
Revenue
28
Cost of Revenue
6
Gross Profit
22
Gross Margin
79.2%
Operating Income
-19
Operating Margin
-69.2%
Net Income
-36
Net Margin
-129.6%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-17
EBITDA Margin
-63.3%
2020
12/31/2020
Revenue
14
Cost of Revenue
7
Gross Profit
7
Gross Margin
51.5%
Operating Income
-29
Operating Margin
-211.2%
Net Income
21
Net Margin
148.7%
EPS (Basic)
$1.00
EPS (Diluted)
$0.00
EBITDA
-27
EBITDA Margin
-195.4%